
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
VUV detection extends HPLC sensitivity into 150–290 nm, enabling direct detection of underivatized amino acids with higher signal and linearity than PDA, eliminating the need for derivatization





